| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows provided by (used in) Operating activities: | ||||||||
Net loss | ||||||||
118,000 | 109,000 | -875,000 | -1,138,000 | -1,322,000 | -1,250,000 | 0 | 0 | 0 |
Net income from discontinued operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net loss from continuing operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||||||||
Impairment losses including inventory | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Depreciation and amortization | ||||||||
371,000 | 376,000 | 403,000 | 421,000 | 497,000 | 439,000 | 0 | 0 | 0 |
Amortization of debt issuance costs and other noncash interest expense | ||||||||
13,000 | 11,000 | 8,000 | 8,000 | 9,000 | 9,000 | 0 | 0 | 0 |
Amortization of intangible assets | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Stock-based compensation expense | ||||||||
22,000 | 20,000 | 16,000 | 15,000 | 22,000 | 20,000 | 0 | 0 | 0 |
Foreign exchange losses | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Deferred income tax expense (benefit) | ||||||||
- | - | - | - | - | -48,000 | 0 | 0 | 0 |
Other | ||||||||
-2,000 | 7,000 | 23,000 | 19,000 | 34,000 | 28,000 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Trade and other receivables | ||||||||
-5,000 | 20,000 | 19,000 | -33,000 | -33,000 | 19,000 | 0 | 0 | 0 |
Accounts payables and accrued liabilities | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Accrued compensation and benefits | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Trade and other payables | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Accrued liabilities | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Contract liabilities | ||||||||
-92,000 | -117,000 | -145,000 | -171,000 | -209,000 | -158,000 | 0 | 0 | 0 |
Advances to suppliers | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Deferred tax assets | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Deferred tax liabilities | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Other | ||||||||
0 | - | - | 0 | 0 | - | - | 0 | 0 |
Cash used in operating activities - continuing operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Cash (used in) provided by operating activities - discontinued operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Other | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Cash used in operating activities | ||||||||
360,000 | 317,000 | 233,000 | 199,000 | 94,000 | 139,000 | 0 | 0 | 0 |
Investing activities: | ||||||||
Purchase of property, plant and equipment and development or purchase of software | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Purchase of property, plant and equipment | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Purchase or development of software | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Disposal of subsidiary and short-term investments | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Return of capital from discontinued operations | ||||||||
0 | - | - | - | - | - | - | - | - |
Cash used in investing activities - continuing operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Cash used in investing activities - discontinued operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Cash used in investing activities | ||||||||
8,000 | -13,000 | -198,000 | -164,000 | -168,000 | -150,000 | 0 | 0 | 0 |
Financing activities: | ||||||||
Net proceeds of revolving credit facility | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net proceeds from revolving credit facility | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Repayments of long-term debt | ||||||||
521,000 | 520,000 | 21,000 | 24,000 | 23,000 | 24,000 | 0 | 0 | 0 |
Settlement of securitization liability | ||||||||
20,000 | 20,000 | 10,000 | 17,000 | 15,000 | 15,000 | 0 | 0 | 0 |
Payment of dividends | ||||||||
2,000 | 2,000 | 18,000 | 34,000 | 50,000 | 65,000 | 0 | 0 | 0 |
Payment of finance leases | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Change in overdraft balance | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Other | ||||||||
0 | - | - | - | - | - | - | - | - |
Cash provided by financing activities - continuing operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Cash (used) provided by in financing activities - discontinued operations | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Cash (used in) provided by financing activities | ||||||||
-388,000 | -238,000 | 4,000 | 12,000 | 85,000 | 13,000 | 0 | 0 | 0 |
(Decrease) increase in cash, cash equivalents, and restricted cash | ||||||||
-20,000 | 66,000 | 39,000 | 47,000 | 11,000 | 2,000 | 0 | 0 | 0 |
Effect of foreign exchange on cash, cash equivalents, and restricted cash | ||||||||
- | - | - | 0 | 0 | - | - | - | - |